← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2014Last known activity
Jul 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT06414759CollaboratorPhase 4Jul 1, 2024
- NCT07023016Sponsor investigatorPhase 2/Phase 3Nov 1, 2023
- NCT07023016Lead sponsorPhase 2/Phase 3Nov 1, 2023
- NCT05849766CollaboratorPhase 3Apr 27, 2023
- NCT05364190CollaboratorPhase 3Jun 4, 2022
- NCT05424315Sponsor investigatorPhase 2/Phase 3Oct 1, 2021
- NCT05424315Lead sponsorPhase 2/Phase 3Oct 1, 2021
- NCT04285736CollaboratorPhase 2/Phase 3Dec 31, 2014
- NCT02728518Reponsible party - principal investigatorN/AAug 1, 2014
- NCT02728518Lead sponsorN/AAug 1, 2014
Details
- Last known activity
- Jul 1, 2024